Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama

Lisa Gantz, Arlene Calvo, Morgan Hess-Holtz, Fiorella Gonzales, Lourdes Alguero, Sheila Murphy, Meghan Moran, Lauren B. Frank, Joyee S. Chatterjee, Paula Amezola de Herrera, Lourdes Baezconde-Garbanati

Research output: Contribution to journalArticle

Abstract

In 2008, Panama became the first country in Latin America to offer the Human Papilloma Virus (HPV) vaccine at no cost to 10-year-old girls as part of its National Immunization Program. Vaccine completion rates remain suboptimal, and knowledge is limited regarding public perceptions of the HPV vaccine in Panama. A cross-sectional survey of 333 Panamanian women aged 18–65 was conducted in Panama City, Panama. Although 93 percent of respondents had heard of HPV, only 59.8 percent had heard of the HPV vaccine. Acceptability of HPV vaccination of daughters was high (95 percent). In multivariate analyses, HPV vaccine awareness was associated with age and education, but not with income, Internet use as preferred source of health information, indigenous race, or marital status. Additionally, after controlling for age, education, income, race, and Internet use, women who completed a pap test in the past 36 months were 3.12 times more likely to have heard of the HPV vaccine when compared to those who had not (95%CI 1.04–9.34). Future efforts to educate Panamanian women about the HPV vaccine should include special attention to vulnerable populations, including those of younger age and limited education.

Original languageEnglish (US)
Pages (from-to)95-118
Number of pages24
JournalWorld Medical and Health Policy
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Papillomaviridae
Panama
Papillomavirus Vaccines
Education
Internet
Papanicolaou Test
Immunization Programs
Latin America
Marital Status
Vulnerable Populations
Nuclear Family
Vaccination
Vaccines
Multivariate Analysis
Cross-Sectional Studies
Costs and Cost Analysis

Keywords

  • HPV
  • HPV vaccine
  • Panama

ASJC Scopus subject areas

  • Health Policy

Cite this

Gantz, L., Calvo, A., Hess-Holtz, M., Gonzales, F., Alguero, L., Murphy, S., ... Baezconde-Garbanati, L. (2019). Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama. World Medical and Health Policy, 11(1), 95-118. https://doi.org/10.1002/wmh3.293

Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama. / Gantz, Lisa; Calvo, Arlene; Hess-Holtz, Morgan; Gonzales, Fiorella; Alguero, Lourdes; Murphy, Sheila; Moran, Meghan; Frank, Lauren B.; Chatterjee, Joyee S.; Amezola de Herrera, Paula; Baezconde-Garbanati, Lourdes.

In: World Medical and Health Policy, Vol. 11, No. 1, 01.03.2019, p. 95-118.

Research output: Contribution to journalArticle

Gantz, L, Calvo, A, Hess-Holtz, M, Gonzales, F, Alguero, L, Murphy, S, Moran, M, Frank, LB, Chatterjee, JS, Amezola de Herrera, P & Baezconde-Garbanati, L 2019, 'Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama', World Medical and Health Policy, vol. 11, no. 1, pp. 95-118. https://doi.org/10.1002/wmh3.293
Gantz, Lisa ; Calvo, Arlene ; Hess-Holtz, Morgan ; Gonzales, Fiorella ; Alguero, Lourdes ; Murphy, Sheila ; Moran, Meghan ; Frank, Lauren B. ; Chatterjee, Joyee S. ; Amezola de Herrera, Paula ; Baezconde-Garbanati, Lourdes. / Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama. In: World Medical and Health Policy. 2019 ; Vol. 11, No. 1. pp. 95-118.
@article{f1f70cf13b4f45cb8fe320ddf2a572dd,
title = "Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama",
abstract = "In 2008, Panama became the first country in Latin America to offer the Human Papilloma Virus (HPV) vaccine at no cost to 10-year-old girls as part of its National Immunization Program. Vaccine completion rates remain suboptimal, and knowledge is limited regarding public perceptions of the HPV vaccine in Panama. A cross-sectional survey of 333 Panamanian women aged 18–65 was conducted in Panama City, Panama. Although 93 percent of respondents had heard of HPV, only 59.8 percent had heard of the HPV vaccine. Acceptability of HPV vaccination of daughters was high (95 percent). In multivariate analyses, HPV vaccine awareness was associated with age and education, but not with income, Internet use as preferred source of health information, indigenous race, or marital status. Additionally, after controlling for age, education, income, race, and Internet use, women who completed a pap test in the past 36 months were 3.12 times more likely to have heard of the HPV vaccine when compared to those who had not (95{\%}CI 1.04–9.34). Future efforts to educate Panamanian women about the HPV vaccine should include special attention to vulnerable populations, including those of younger age and limited education.",
keywords = "HPV, HPV vaccine, Panama",
author = "Lisa Gantz and Arlene Calvo and Morgan Hess-Holtz and Fiorella Gonzales and Lourdes Alguero and Sheila Murphy and Meghan Moran and Frank, {Lauren B.} and Chatterjee, {Joyee S.} and {Amezola de Herrera}, Paula and Lourdes Baezconde-Garbanati",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/wmh3.293",
language = "English (US)",
volume = "11",
pages = "95--118",
journal = "World Medical and Health Policy",
issn = "2153-2028",
publisher = "Berkeley Electronic Press",
number = "1",

}

TY - JOUR

T1 - Predictors of HPV Knowledge and HPV Vaccine Awareness Among Women in Panama City, Panama

AU - Gantz, Lisa

AU - Calvo, Arlene

AU - Hess-Holtz, Morgan

AU - Gonzales, Fiorella

AU - Alguero, Lourdes

AU - Murphy, Sheila

AU - Moran, Meghan

AU - Frank, Lauren B.

AU - Chatterjee, Joyee S.

AU - Amezola de Herrera, Paula

AU - Baezconde-Garbanati, Lourdes

PY - 2019/3/1

Y1 - 2019/3/1

N2 - In 2008, Panama became the first country in Latin America to offer the Human Papilloma Virus (HPV) vaccine at no cost to 10-year-old girls as part of its National Immunization Program. Vaccine completion rates remain suboptimal, and knowledge is limited regarding public perceptions of the HPV vaccine in Panama. A cross-sectional survey of 333 Panamanian women aged 18–65 was conducted in Panama City, Panama. Although 93 percent of respondents had heard of HPV, only 59.8 percent had heard of the HPV vaccine. Acceptability of HPV vaccination of daughters was high (95 percent). In multivariate analyses, HPV vaccine awareness was associated with age and education, but not with income, Internet use as preferred source of health information, indigenous race, or marital status. Additionally, after controlling for age, education, income, race, and Internet use, women who completed a pap test in the past 36 months were 3.12 times more likely to have heard of the HPV vaccine when compared to those who had not (95%CI 1.04–9.34). Future efforts to educate Panamanian women about the HPV vaccine should include special attention to vulnerable populations, including those of younger age and limited education.

AB - In 2008, Panama became the first country in Latin America to offer the Human Papilloma Virus (HPV) vaccine at no cost to 10-year-old girls as part of its National Immunization Program. Vaccine completion rates remain suboptimal, and knowledge is limited regarding public perceptions of the HPV vaccine in Panama. A cross-sectional survey of 333 Panamanian women aged 18–65 was conducted in Panama City, Panama. Although 93 percent of respondents had heard of HPV, only 59.8 percent had heard of the HPV vaccine. Acceptability of HPV vaccination of daughters was high (95 percent). In multivariate analyses, HPV vaccine awareness was associated with age and education, but not with income, Internet use as preferred source of health information, indigenous race, or marital status. Additionally, after controlling for age, education, income, race, and Internet use, women who completed a pap test in the past 36 months were 3.12 times more likely to have heard of the HPV vaccine when compared to those who had not (95%CI 1.04–9.34). Future efforts to educate Panamanian women about the HPV vaccine should include special attention to vulnerable populations, including those of younger age and limited education.

KW - HPV

KW - HPV vaccine

KW - Panama

UR - http://www.scopus.com/inward/record.url?scp=85063196234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063196234&partnerID=8YFLogxK

U2 - 10.1002/wmh3.293

DO - 10.1002/wmh3.293

M3 - Article

AN - SCOPUS:85063196234

VL - 11

SP - 95

EP - 118

JO - World Medical and Health Policy

JF - World Medical and Health Policy

SN - 2153-2028

IS - 1

ER -